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Abstract 
Two novel amide glycosides, named oleraciamide E (1) and oleraciamide F (2), were 
isolated from the Portulaca oleracea L. Their structures were determined by means of 
1D and 2D NMR spectroscopic and UHPLC-ESI-TOF-MS methods. Oleraciamide E 
(1) exhibited anticholinesterase activity with IC50 values of 52.43 ± 0.33 μM, and 
presented scavenging activity in 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical 
quenching assay with the IC50 values of 24.64 ± 0.33 μM. 
 
Keywords: Portulaca oleracea L.; amide glycosides; anticholinesterase activity; 
antioxidant activity 
 
  
1. Introduction 
 
Portulaca oleracea L. is an annual succulent herb belonging to a member of the 
Portulacaceae family, which is widely distributed in different geographical 
environments all over the world (Zheng et al. 2018). In China, P. oleracea L. has 
been used as a traditional Chinese medicine (TCM) for thousands of years (Lei et al. 
2015) because it exhibits many pharmacological effects, such as anti-inflammatory 
(Meng et al. 2016), antibacterial (Chan et al. 2015), anticholinesterase (Xiu et al. 
2018), antioxidant (Lim et al. 2007), antitumor (Shen et al. 2013), neuroprotective 
(Sumathi et al. 2016), and so on. Therefore, more and more scholars paid more 
attention on its therapeutic substances, until now, many active ingredients have been 
isolated from the plants, for instance, alkaloids (Jiao et al. 2015, Li et al. 2016, Li et 
al. 2017, Xu et al. 2017, Jiang et al. 2018, Zhao et al. 2018, Zhao et al. 2019, Ma et 
al. 2019), flavonoids (Yang et al. 2018, Yang et al. 2018), organic acids (Wang et al. 
2017), terpenoids (Xin et al. 2008), lignans (Ma et al. 2018), etc. This study is aim to 
isolate the bioactive substance from P. oleracea L. and investigate their activities. As 
a result, two novel amide glycosides named oleraciamide E (1) and oleraciamide F 
(2), shown in Figure 1, were isolated from the P. oleracea L., furthermore, the 
antioxidant and anticholinesterase activities of oleraciamide E (1) were studied. 
 
 
Figure 1. Structure of compounds 1 and 2. 
 2. Results and discussion 
 
Compound 1 was obtained as yellow green powder turned orange when sprayed 
Dragendorff’s reagent. UV (MeOH) λmax 310 nm. IR (KBr) vmax 3382，3256，2920， 
2849，1607，1514，1490，1443，1389，1175，1028，998，831 and 773 cm-1. 
The molecular formula of compound 1 was identified as C22H25NO10 with 11 degrees 
of unsaturation, which was deduced from the NMR data (Table S1, in supplementary 
material) and UHPLC-ESI-TOF-MS at m/z 464.1547 [M+H]+ (calcd 464.1552). 
According to the 13C NMR, the DEPT 135 and the HSQC spectra, Compound 1 
possesses 22 carbon signals, including 2 methylenes (δC 33.5, 62.6), 13 methines 
including 5 aliphatic carbons (δC 69.2, 73.5, 76.0, 77.0, 104.2) and 8 olefinic carbons 
(δC 108.6, 111.7, 115.7, 118.0, 129.4, 139.9, in which 115.7 and 129.4 were 
overlapped), 7 quaternary carbons, including 1 carbonyl carbon (δC 163.9) and 6 
olefinic carbons (δC 126.1, 126.2, 136.1, 143.2, 143.6, 159.1). The 
1H NMR (600 
MHz, DMSO-d6) and 
13C NMR (150 MHz, DMSO-d6) data are listed in (Table S1, in 
supplementary material). An AA′BB′ spin was established by the hydrogen signals at 
δH 6.78 (2H, d, J = 8.28Hz), δH 7.41 (2H, d, J = 9.36 Hz) and the carbon signals at δC 
115.7 (C-3 and C-5, overlapped), δC 129.4 (C-2 and C-6, overlapped). The 
13C NMR 
signal C-4 (δC 159.1) locates at low field area indicated that C-4 connected with a 
hydroxyl. The HMBC correlations from H-3′ to C-2, C-6, and from H-2′ to C-1, and 
from H-3, H-5 to C-1, revealed direct connection of H-3′ with C-1. The 1H NMR signal 
indicated that H-2′ (δH 6.68, 1H, d, J = 15.24 Hz), H-3′ (δH 7.39, 1H, d, J = 15.50 Hz) 
belonged to trans double bond. The HMBC correlations from H-2′, H-3′ to the 
carbonyl at C-1′ (δC 163.9) indicated that the double bond linked to the amide 
carbonyl (δC 163.9). The HMBC correlations from H-2′ to C-2′′ indicated that 
C-2′′ linked to the amide group. The signals at H-3′′′ (1H, s, δH 8.12), H-6′′′ (1H, s, δH 
6.64) are typical of a tetrasubstituted aromatic ring. The 13C NMR signal C-2′′′ (δC 
143.6), C-5′′′ (δC 143.2) at low field area indicated that C-2′′′, C-5′′′ linked to hydroxyl. 
The HMBC correlations from H-6′′′ to C-2′′ and from H-2′′ to C-2′′′, and from H-2′′ to C-
1′′′, indicated that C-2′′ linked to C-1′′′. The HMBC correlations from H-2′′′′ to the 
carbon at C-4′′′ (δC 104.2), the NOESY correlations from H-2′′′′ to H-3′′′ and the 
coupling constant of H-2′′′′, 6.84 indicated that C-4′′′ linked to β-D-glucose. Overall, 
compound 1 was identified as the (E)-N-(2,5-dihydroxy-4-((3,4,5-trihydroxy-6-
(hydroxymethyl)tetrahydro-2H-pyran-2- yl)oxy)benzyl)-3-(4-
hydroxyphenyl)acrylamide, named oleraciamide E (1) (Experimental section, in 
supplementary material). 
 
Compound 2 was obtained as yellow green powder turned orange when sprayed 
Dragendorff’s reagent. its molecular formula was identified as C23H27NO11 with 11 
degrees of unsaturation only by comparing the 1H-1H COSY and ROESY data with 
compound 1 due to its low content (Table S2, in supplementary material), 
additionally, it was deduced from the UHPLC-ESI-TOF-MS at m/z 314.1024 [M-
C6H12O6+H]
+ (calcd 314.1023) (Figure S21, in supplementary material). Compared 
the 1H NMR and 1H-1H COSY signal with compound 1, H-2′ (δH 6.73, 1H, d, J = 15 
Hz), H-3′ (δH 7.39, 1H, d, J = 15 Hz) belonged to trans double bond of the compound 
2, and the H-2 (1H, s, δH 7.16), H-5 (1H, d, δH 7.02) and H-6 (1H, d, δH 6.79) were 
the signals of 1,3,4-tribstituted aromatic ring. The signals δC 55.0/δH 3.80 (3H, s) are 
typical of a methoxy group, and a methoxy group can be placed in C-3 based on the 
ROESY correlation of the methyl protons with H-2 also indicated that the compound 
has a 3-spin system. Taken together, compound 2 was identified as the (E)-N-(2,5-
dihydroxy-4-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2- 
yl)oxy)benzyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide, named oleraciamide F (2) 
(Experimental section, in supplementary material). 
 
Alzheimer's disease (AD), an irreversible progressive neurodegenerative disorder of 
the central nervous system (CNS), is characterized by a gradual loss of cognitive 
ability in the elderly (Jiang et al. 2018). At present, clinical treatment strategies for AD 
are used mainly to improve cholinergic neurotransmission in the brain, and these 
treatments are mostly based on the cholinergic hypothesis (Hu et al. 2019). 
Acetylcholinesterase (AChE) plays a significant role in the termination of nerve 
impulse transmission at the cholinergic synapses by rapid hydrolysis of acetylcholine 
(ACh) (Yang et al. 2012), AChE inhibitors are therefore being the first choice of drugs 
for the treatment of AD (Kaufmann et al. 2016). In this study, compound 1 exerted an 
inhibitory activity against the AChE with dose-dependent (Figure S14, in 
supplementary material) with the IC50 values of 52.43 ± 0.33 μM (Table S3, in 
supplementary material). The antioxidant activity of the compound 1 was performed 
using the DPPH radical scavenging method (María I. Gil et al. 2000). The results 
indicated that compound 1 presented higher antioxidant activity than that of BHA 
(Table S4, in supplementary material) as its phenolic hydroxyl groups played an 
important role in scavenging DPPH radical (Yang et al. 2009), and the antioxidant 
activity of compound 1 was dose-dependent (Figure S15, in supplementary material). 
 
3. Conclusion 
 In this study, two novel amide glycosides, oleraciamide E and oleraciamide F 
possessing similar structures, were isolated from P. oleracea L. for the first time, and 
compound 1 presented remarkably anticholinesterase and antioxidant effects. 
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Supporting information can be found in the online version of this article. 
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